CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | Paulson Richard A. President and CEO | Sale | −2,542 | $5.76 | $15K | 630,906 |
| 2022-06-03 | Mason Michael EVP, CFO, Treasurer | Sale | −598 | $6.04 | $4K | 138,512 |
| 2022-06-03 | Mason Michael EVP, CFO, Treasurer | Sale | −3 | $6.07 | $18 | 138,509 |
| 2022-05-19 | Schor Chen Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2022-05-19 | PAKIANATHAN DEEPIKA Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2022-05-19 | Oliger Christy J. Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2022-05-19 | Mirza Mansoor Raza Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2022-05-19 | Honig Peter Director | Grant or award · Nonstatutory Stock Option (right to buy) | +10,995 | 10,995 | ||
| 2022-05-19 | BOHLIN GAREN G Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2022-05-19 | Greene Barry E Director | Grant or award · Nonstatutory Stock Option (right to buy) | +23,900 | 23,900 | ||
| 2022-05-04 | Paulson Richard A. President and CEO | Sale | −633 | $6.26 | $4K | 661,317 |
| 2022-05-04 | Paulson Richard A. President and CEO | Sale | −27,869 | $6.23 | $174K | 633,448 |
| 2022-04-29 | Rangwala Reshma EVP & Chief Medical Officer | Grant or award | +65,000 | 65,000 | ||
| 2022-04-29 | Rangwala Reshma EVP & Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-03-29 | Shacham Sharon Chief Scientific Officer | Grant or award | +60,000 | 958,131 | ||
| 2022-03-29 | Shacham Sharon Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-02-28 | Frenkel Ran EVP, Chief Dev. Officer | Grant or award | +68,250 | 169,953 | ||
| 2022-02-28 | Frenkel Ran EVP, Chief Dev. Officer | Sale | −1,663 | $10.24 | $17K | 168,290 |
| 2022-02-28 | Frenkel Ran EVP, Chief Dev. Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2022-02-28 | Mason Michael EVP, CFO & Treasurer | Grant or award | +88,200 | 141,508 |
Page 13 of 15 · 287 trades